CD9 and cancer: Using the same recovery and the measured EV number for anti CD9 antibody labelled EVs (Figure 5b), about 1.7 (± 0.9) × 1010 particles/ml were calculated for respective human cancer patient serum, which is slightly higher than estimated EV concentrations so far (Table 1/Lit).